2 nd Joint Sino German Symposium 2018 Globalization Challenge and Response for Infectious Diseases
|
|
|
- Chester Dixon
- 5 years ago
- Views:
Transcription
1 Globalization Challenge and Response for Infectious Diseases Hamburg, September 3 to 5, 2018 Hosted by Location Heinrich Pette Institute, Leibniz Institute for Experimental Virology (HPI) National Institute for Viral Disease Control and Prevention, China CDC (IVDC) HPI, Martinistraße 52, Hamburg, Building N63 & Lecture Hall N61 MONDAY September 3, Registration 注册 Welcome Address by German Officials Chair: Thomas Dobner (HPI) confirmed: State Council Eva Gümbel, Hamburg Ministry of Science, Research and Equality (BWFG) Session 1: Challenges and preparedness for global emerging and re-emerging infectious diseases Chair: Wolfram Brune (HPI) 10:30-10:50: XU Wenbo (IVDC): Ebola RNA persistence in semen of Ebola virus disease survivors 10:50-11:10: LIANG Mifang (IVDC): Epidemiological characteristics of severe fever with Thrombocytopenia Syndrome (SFTS) in China from first discovery 11:10 Coffee 茶歇 11:40 11:40-12:10 Gülsah Gabriel (HPI): Molecular determinant of avian influenza A virus interspecies transmission from birds to man 12:10-12:30 LU Zhuozhuang (IVDC): Novel human and fowl adenoviral vectors for vaccine development 12:30-12:50 Isam Mohamed Elkhidir (University of Khartoum): Hemorrhagic fever in Sudan 12:50-13:10 WEI Qiang (IVDC): The network of national pathogenic microorganism culture in China 1
2 13.10 Lunch 午餐 :40-15:10 César Muñoz-Fontela (BNITM): Diagnostics and research of Ebola virus in Africa 15:10-15:30 LIU Jun (IVDC): Antigen-specific T-cell immunity in human against emerging and reemerging viruses 15:30-15:50 SONG Jingdong (IVDC): Pathogen spectrum investigation of Febrile Jaundice patients and molecular signatures of one human monkeypox infection in Sierra Leone, :50-16:20 N.N Coffee 茶歇 Session 2: Challenges of commonly faced infectious diseases in China and Germany Chair: DUAN Zhaojun 段招军 (IVCD) 16:50-17:10 LI Zhongjie (China CDC): The achievements and challenges of infectious diseases control in China 17:10-17:30 SHI Weifeng (School of Basic Medical Sciences, Taishan Medical College): Origin, transmission and evolution of novel human-infecting influenza viruses in China 17:30-18:00 Ralf Bartenschlager (Universitätsklinikum Heidelberg): News insights into Flaviviridae host cell interactions 18:00-18:20 ZHANG Yan (IVDC): The nationwide laboratory network to support the elimination of measles and rubella and its challenges 18:20-18:40 GAO Rongbao (IVDC): The emerging novel avian influenza viruses infecting humans in China since :40-19:10 Thomas Dobner (HPI): The 2 nd Symposium of Chinese-German Virology Advanced strategies to combat infectious diseases 19:10-19:30 WANG Huangyu (IVDC): Arbovirus in China 19:30-19:50 SHEN Liping (IVDC): Molecular epidemiological surveillance and analysis of hepatitis B virus in China Reception 接待 Closed Session IVDC and HPI representatives, Part I 2
3 TUESDAY September 4, :00 Session 3: Pathogenic identification and data analysis Chair: Kay Grünewald (HPI) 09:00-09:20 CHEN Zhihai (Beijing Ditan Hospital, Capital Medical University): Clinical research on severe fever with thrombocytopenia syndrome (SFTS) 09:20-09:50 Stefan Niemann (FZB): Evolution and transmission of drug resistant M. tuberculosis strains 09:50-10:10 PENG Junping (Institute of Pathogen Biology (IPB), Chinese Academy of Medical Sciences (CAMS): Application of multiplex PCR coupled with matrix-assisted laser desorption Ionization Time of flight analysis for pathogen detection 10:10-10:30 ZHU Wuyang (IVDC): Rapid, specific detection of Alphaviruses from tissue cultures using a replicon-defective reporter gene assay 10:30 Coffee 茶歇 11:00 11:00-11:30 Martin Beer (FLI): NGS-based metagenomics the next level of diagnostics 11:30-11:50 HAN Jun (IVDC): Non-structural protein 2B of human rhinovirus induces increase of cytoplasmic Ca2+ to cause ER stress through activation of both PERK and ATF6 pathways rather than IRE1 pathway 11:50-12:10 MA Xuejun (IVDC): Rapid and accurate sequencing of enterovirus genomes using MinIONNanopore sequencer 12:10-12:40 N.N Lunch 午餐 Session 4: Structural insights into pathogen infections Chair: Prof. XU Wenbo (IVDC) 14:00-14:30 Kay Grünewald (HPI): Integrated structural cell biology of virus-host interactions 14:30-15:00 Norbert Tautz (UzL): Structural basis for the switch between RNA replication and virion morphogenesis in pestiviruses 15:00-15:20 PENG Ruchao (Institute of Microbiology, CAS): Structures and functions of orthomyxovirus envelope glycoproteins Coffee 茶歇 3
4 :50-16:20 Charlotte Uetrecht (HPI): Flying viruses from biophysical to structural characterization 16:20-16:50 Reidun Twarock (University of York): A systems virology approach to virus structure, assembly and evolution opens up new opportunities for therapy 16:50-17:20 Maya Topf (University of London): An integrative approach to decipher protein-protein interactions and assembly structures in herpesviruses Reception 接待 Closed Session IVDC and HPI representatives, Part II WEDNESDAY September 5, Session 5: One Health (Part I) Chair: Thomas Dobner (HPI) 09:00-09:20 SHI Zhengli (IVDC): Risk assessment of bat coronavirus spillover and prevention strategy 09:20-09:50 Stefanie Becker (TiHo Hannover): Of insects and mammals: Deciphering molecular mechanisms of arbovirus replication cycles 09:50-10:20 Alex Greenwood (IZW Berlin): Water and infectious disease: The influence of wildlife, ecology and urbanization Coffee 茶歇 :40-11:00 ZHAO Chihong (China CDC): Standard laboratory management promotes the prevention and control of infectious diseases China's experience. 11:00-11:30 Veronika von Messling (PEI): Understanding Morbillivirus pathogenesis to control disease and transmission 11:30-11:50 TAN Wenjie (IVDC): Novel broad-spectrum inhibitors of coronaviruses infection based on FDA - approved drugs 11:50-12:10: LIU Di (Wuhan Institute of Microbiology, CAS): Viral genomics and evolution Lunch 午餐 4
5 13.40 Session 5: One Health (Part II) Chair: TAN Wenjie (IVDC) 13:40-14:10 Stephanie Stanelle-Bertram (HPI): Impact of maternal ZIKV infection on fetal health 14:10-14:30 MENG Lei (Gansu Provincial CDC): The new challenge on prevent and control for vaccine preventable infectious diseases - the situation on adult incidence in Gansu 14:30-15:00 Marylyn Addo (UKE): Vaccines against emerging viruses- Update on MERS-CoV vaccine development Coffee 茶歇 :30-15:50 WANG Shiwen (IVDC): Surveillance and diagnosis of SFTS in China 15:50-16:10 DUAN Zhaojun (IVDC): Glycan receptor for rotavirus and norovirus 16:10-16:30 ZHANG Yong (IVDC): Research on network monitoring and traceability technology system based on whole genomes of viruses Farewell Event 欢送 5
Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security
Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security May 17-19 2017, Wuhan, China Meeting Program Note: Each report will take 25 minutes including
PROGRAM RNA VIRUS PERSISTENCE MEETING: MECHANISMS AND CONSEQUENCES. AUGUST 23-25, 2018 Institute of Virology, Medical Center - University of Freiburg
PROGRAM RNA VIRUS PERSISTENCE MEETING: MECHANISMS AND CONSEQUENCES AUGUST 23-25, 2018 Institute of Virology, Medical Center - University of Freiburg WELCOME Mechanisms and consequences of RNA virus persistent
Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences
Avian Influenza Virus H7N9 Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus RNA virus, Orthomyxoviruses Influenza A virus Eight Gene segments
Microbiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during
(Abroad Domestic)Official trip report form(student) 2014/08/19 (Year/Month/Day) Name Laboratory Year (Grade) Destination Nipawit Karnbunchob Division of Bioinformatics DC2 Montreal, CANADA Period of trip
Emerging infectious disease: trends in the literature on SARS and H7N9 influenza
Scientometrics (2015) 105:485 495 DOI 10.1007/s11192-015-1681-8 Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Deqiao Tian 1 Tao Zheng 1 Received: 19 July 2015 / Published
Identifying, Preparing for & Reducing Pandemic Risk
Identifying, Preparing for & Reducing Pandemic Risk Jonna Mazet, DVM, MPVM, PhD Professor of Epidemiology & Disease Ecology One Health Institute School of Veterinary Medicine University of California,
Biomed Environ Sci, 2016; 29(6):
Biomed Environ Sci, 2016; 29(6): 443-447 443 Letter to the Editor Detection and Analysis of Ebola Virus in Sierra Leone-China Friendship Biosafety Laboratory from March 11 to April 20, 2015 * WANG Qin
Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM
Viruses: Select Agents and Emerging Pathogens Patricia Bolívar MS., CLS, PHM Objectives Review Select Agent Viruses. Key features to recognize Smallpox virus Update on emerging Viruses of possible pandemic
EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?
8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct
The Ebola Virus. By Emilio Saavedra
The Ebola Virus By Emilio Saavedra Etiological Agents: Ebolavirus is the etiologic agent. [1] There are four main families of viruses that are agents of Ebola (hemorrhagic fever). [1] These four families
SUMMARY OF THE DISCUSSION AND RECOMMENDATIONS OF THE SARS LABORATORY WORKSHOP, 22 OCTOBER 2003
SUMMARY OF THE DISCUSSION AND RECOMMENDATIONS OF THE SARS LABORATORY WORKSHOP, 22 OCTOBER 2003 An informal SARS Laboratory Workshop was held at WHO, Geneva, on Wednesday, 22 October 2003, to discuss aspects
Killer Viruses: The Why and The How. Amesh Adalja
Killer Viruses: The Why and The How Amesh Adalja MD @AmeshAA Disclosures Stockholder: Merck, Luminex, Evolent Bondholder: UPMC Speaker s Bureau: Merck, Roche Consultant: Roche Funding: Open Philanthropy
The 10 th Japan-Taiwan Symposium on Vaccine Preventable Diseases and Vector-Borne Diseases
The 10 th Japan-Taiwan Symposium on Vaccine Preventable Diseases and Vector-Borne Diseases September 12-13, 2013 the National Institute of Infectious Diseases, Tokyo, JAPAN September 12, Thursday Opening
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
Advanced Lecture on One Health
The 6th International Symposium Advanced Lecture on One Health 13:30~16:30 Sept 2, 2013 Lecture Hall, Graduate School of Veterinary Medicine, Hokkaido University, JAPAN Program 13:30~14:30 Dr. Ruben Donis
Enterovirus 71 Outbreak in P. R. China, 2008
JCM Accepts, published online ahead of print on 13 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00563-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug
1) understand the structure and life cycle of viruses as well as viral evolution. 2) know the mechanisms of host immune responses to viral infections
VIROLOGY A The course aims to provide the student with the cognitive and methodological tools necessary to: 1) understand the structure and life cycle of viruses as well as viral evolution 2) know the
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval
International Hepatitis Symposium Heidelberg
16 th May 18 th May 2018 International Hepatitis Symposium Heidelberg Ralf Bartenschlager s 60 th Birthday Symposium (16 th ) AND International Symposium of the TRR179 (17 th to 18 th ) Confirmed Speakers:
Update August Questions & Answers on Middle East Respiratory Syndrome Coronavirus (MERS CoV)
Update August 2014 - Questions & Answers on Middle East Respiratory Syndrome Coronavirus (MERS CoV) What is MERS-CoV? MERS-CoV is a coronavirus (CoV) which causes Middle East Respiratory Syndrome (MERS),
Aseptic meningitis: inflammation of meninges with sterile CSF (without any causative organisms which can be grown on culture media).
You have to refer to the slides, since I have included the extra information only. Slide #1: Both illnesses aseptic meningitis and encephalitis can be caused by the same viruses; that viruses which cause
Linfa Wang CSIRO Australian Animal Health Laboratory (AAHL) 5740 papers. in 12 minutes?!
SARS Linfa Wang CSIRO Australian Animal Health Laboratory (AAHL) 5740 papers. in 12 minutes?! 1 Joint mission to China on Animal Reservoir of the SARS-CoV and potential transmission to humans (August 9
AREAS OF CONCENTRATION
Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite
Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 2015 (covering week )
The The Influenza B in certain countries8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 st January 215 (covering week 3 215) Current level of activity: Low Trend: Decreased
VIP: an integrated pipeline for metagenomics of virus
VIP: an integrated pipeline for metagenomics of virus identification and discovery Yang Li 1, Hao Wang 2, Kai Nie 1, Chen Zhang 1, Yi Zhang 1, Ji Wang 1, Peihua Niu 1 and Xuejun Ma 1 * 1. Key Laboratory
III. What are the requirements for taking and passing this course?
1 Molecular Virology Lecture # 1: Course Introduction I. Instructor and Background Dr. Richard Kuhn rjkuhn@bragg.bio.purdue.edu B-129 Lilly Hall 494-1164 Office Hours - Wednesday 10:30-11:30 II. Objective:
Influenza: The past, the present, the (future) pandemic
Influenza: The past, the present, the (future) pandemic Kristin Butler, MLS (ASCP) cm Department of Clinical Laboratory Sciences Louisiana Health Sciences Center - Shreveport Fall 2017 Objectives 1) Detail
Currently, the Department of Epidemiology has 5 rooms / offices undertake various professional roles:
National Institute of Hygiene and Epidemiology (NIHE) Hanoi Vietnam Department of Epidemiology Currently, the Department of Epidemiology has 5 rooms / offices undertake various professional roles: Room
INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day
INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) April 28, 2016 Arlington, VA INTERCEPT Agenda INTERCEPT
Modeling the Antigenic Evolution of Influenza Viruses from Sequences
Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.
J. A. Sands, 21 October 2013 Lehigh University
J. A. Sands, 21 October 2013 Lehigh University Cryptococcus, Candidiasis, Aspergillosis Tuberculosis Cholera Plague Bact. Meningitis Salmonella Listeria Leptospirosis Staph. (MRSA) E. coli Clostridium
INFLUENZA-2 Avian Influenza
INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature
Swine Acute Diarrhea Syndrome Coronavirus (SADS-CoV) in China
Community for Emerging and Zoonotic Diseases CEZD EMERGING DISEASE RISK PROFILE This document is a product of the Community for Emerging and Zoonotic Diseases. It is a preliminary assessment, and may be
Adolfo Garcia-Sastre, New York, USA
Program Overview Sunday, September 21, 2014 15.00 Registration 18.00 22.00 OPENING 18.00 Welcome note by the organizers 18.15 Opening lecture: Interactions of the influenza virus NS1 with the host. Adolfo
Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University
Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments
Public health relevant virological features of Influenza A(H7N9) causing human infection in China
Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional
Mapping the Global Virome. Making the Unknown Known. And the World Safe From a Future of Viral Threats
Mapping the Global Virome Making the Unknown Known. And the World Safe From a Future of Viral Threats If you know your enemies and know yourself, you will not be imperiled in a hundred battles;..if you
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-03-08 23:26:29 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Transmissible
Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center
Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center Definitions: Epidemic The occurrence of cases of an illness in a community or region which
Day1- Monday 7 May 2018 OPENING REMARKS AND COURSE INTRODUCTION EPIDEMIOLOGY AND ECOLOGY VIROLOGY
Day1- Monday 7 May 2018 OPENING REMARKS AND COURSE INTRODUCTION 08.30 09.00 Hassan Zaraket (Faculty of Medicine, American University of Beirut, Lebanon) & John Wood (National Institute for Biological Standards
Zika Virus Basics. Flaviviridae Flavivirus Disease Vector Vaccine *Dengue (serotypes 1-4) Zika Virus Basics. Zika Virus Transmission Cycle
Zika: Infection,, and Protection Roxanne P. Liles, Ph.D., MLS(ASCP) CM Assistant Professor of Biology Louisiana State University at Alexandria 318-473-6518 rliles@lsua.edu Zika Virus Basics Virion: Enveloped
Part I. Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents.
Viruses Part I Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents. History Through the 1800s, many scientists discovered that something
Rotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016
Rotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016 Loading Virus Pathogen Database and Analysis About Resource
MERS H7N9. coronavirus. influenza virus. MERS: Since September 2012: 160 cases, including 68 deaths (42%)
MERS coronavirus H7N9 influenza virus Marc Van Ranst, KU Leuven MERS: Since September 2012: 160 cases, including 68 deaths (42%) MERS coronavirus patient, 83 years, Saudi-Arabia H7N9: Since February 2013:
LECTURE topics: 1. Immunology. 2. Emerging Pathogens
LECTURE 23 2 topics: 1. Immunology 2. Emerging Pathogens Benefits of the Normal Flora: 1. Protect us from colonization by other bacteria and fungi (competitive exclusion). 2. Many synthesize vitamins,
Discovery of. 1892: Russian biologist Dmitri Ivanovsky publishes. 1931: first images of viruses obtained using
Discovery of (1884: invention of the Chamberland filter with pores smaller than bacteria) 1892: Russian biologist Dmitri Ivanovsky publishes a paper in which shows that extracts from diseased tobacco plants
Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?
Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)
4 th ONE-HEALTH COURSE. (Preliminary program)
4 th ONE-HEALTH COURSE (Preliminary program) 4-20 April 2016 Monday 4 April 2016 9h00-10h30 WEEK 1 WELCOME TO THE COURSE : PRESENTATION OF PROFESSORS AND STUDENTS Myriam ERMONVAL, Marc SAVEY & Noël TORDO
VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON
VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION
Trends of Pandemics in the 21 st Century
Trends of Pandemics in the 21 st Century 1 H5N1 influenza, Hong Kong, 1997: 18 human infections/6 deaths 500 450 400 350 300 250 200 150 100 50 0 #H5N1 #sampled Parks Live domesticated foul markets Source:
OIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-01-17 13:49:58 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Highly
Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA
Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Technical Advisor, United States Agency for International Development (USAID) Chair, WONCA Working
Chapter 38 Viral Infections
Chapter 38 Viral Infections Primary Objectives of This Chapter Chapter 38 introduces a wide variety of important human viral diseases and serves as an introduction to Medical Virology. It is considered
Avian Influenza A(H7N9) 13 February 2014 Surveillance Update
Avian Influenza A(H7N9) 13 February 2014 Surveillance Update Summary The WHO has reported 337 human infections including 66 deaths with onset since February 2013. There are still no signs of ongoing, efficient,
Diagnosis of infectious diseases and confirmation of diagnosis. Molecular epidemiology of emerging/re-emerging pathogens
LA PREPARAZIONE E LA RISPOSTA ALLE EMERGENZE INFETTIVE Padova, 20 settembre 2012 Laboratory advanced technologies in the support of Public Health interventions in infectious disease emergencies Prof. Giorgio
History electron microscopes
Viruses History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin word- poison) In the 1930s, after the invention of
Viral Taxonomic Classification
Viruses Part I Viral Taxonomic Classification Order>> -virales Family>> - viridae Subfamily>> -virinae Genus>> -virus Species Order>> Picornavirales Family>> Picornaviridae Subfamily>> Picornavirinae Genus>>
The 12th Japan-Taiwan Symposium on. Emerging and re-emerging infectious diseases, Vaccine Preventable Diseases and Collaborative Project Reports
The 12th Japan-Taiwan Symposium on Emerging and re-emerging infectious diseases, Vaccine Preventable Diseases and Collaborative Project Reports September 10-11, 2015 National Institute of Infectious Diseases,
Challenges and opportunities in risk assessment for viruses Marion
Challenges and opportunities in risk assessment for viruses Marion Koopmans @MArionKoopmans Estimates of foodborne viral disease, US Estimated nr FB cases Per 100000 Estimated nr hospitalisations Estimated
Tis the Season Respiratory that is
Tis the Season Respiratory that is Jason LeBlanc Director Virology, Immunology, Molecular Microbiology, NHSA Central Objectives Understand the etiology and epidemiology of viral respiratory tract infection
Marmoset-based infectious disease research under biocontainment conditions
Marmoset-based infectious disease research under biocontainment conditions Jean Patterson, PhD Texas Biomedical Research Institute October 22 nd, 2018 West Nile virus Common marmoset found to be equivalently
Y E N E W S L E T T E R
Y O U N G E P I Z O N E V O L U M E 9 Y E N E W S L E T T E R J U N E 2 0 1 7 W E L C O M E I N S I D E T H I S I S S U E : W E L C O M E 1 M A D R I D 2 O U R N E W C H A I R M A N 3 Y E C O R E G R O
Coronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Coronaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Spherical enveloped particles studded with clubbed spikes Diameter 120-160 nm Coiled helical
Vaccines: Reaching for higher branches after the low hanging fruit has been picked
Engineering Conferences International ECI Digital Archives Vaccine Technology VI Proceedings 6-12-2016 Vaccines: Reaching for higher branches after the low hanging fruit has been picked Michael G. Kurilla
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Mary Gustafson Vice President, Global Regulatory Policy, PPTA MASAC Update, September 20, 2014 Emerging Viruses and Product Safety Issues to be Addressed Presentation
Zika Virus. It may be devastating, But we might just get one step ahead of it. Learning in Retirement Winter 2017 Daniel Burnside. photo: Newsweek.
Zika Virus It may be devastating, But we might just get one step ahead of it Learning in Retirement Winter 2017 Daniel Burnside photo: Newsweek.com INTRODUCTION TO VIRUSES STRUCTURE GENOME LIFE CYCLE
The Influence of Climate Change on Insect. Director Australian Animal Health Laboratory, Geelong
The Influence of Climate Change on Insect Borne Diseases (1) Professor Martyn Jeggo Professor Martyn Jeggo Director Australian Animal Health Laboratory, Geelong The problem the risk of infectious disease
Current CEIRS Program
History The influenza program at St. Jude has a long, distinguished history as a world-class leader in the study of the origins, evolution, and pathogenesis of influenza viruses. Based on this expertise,
Classification of Infectious Disease Law in Japan
Classification of Infectious Disease Law in Japan Type 1 (7) Type 2 (7) Type 3 (5) Type 4 (44) Viral Hemorrhagic Fever EVD Lassa Fever CCHF Marburg disease South American Hemorrhagic Fevers Plague Smallpox
BC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners
To: Subject: Purpose: Action required: Recommendations: BC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners November 1, 2013 Emerging
Contribution of avian influenza data through OFFLU network
Dr Gounalan Pavade Chargé de Mission, OIE Headquarters Contribution of avian influenza data through OFFLU network Asia-Pacific Workshop on surveillance, prevention and control of zoonotic influenza Paro,
Chapter 6- An Introduction to Viruses*
Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses
CE Unit. Viruses and Vaccines
CE Unit Viruses and Vaccines DO NOT WRITE What is a virus? Have you ever had a virus? What is a vaccine? How is a virus different from bacteria? What are the deadliest viruses? 10. Dengue fever 50 million
USING ADVANCED GENOMIC ANALYSIS FOR POTENTIAL HAEMORRHAGIC FEVER CAUSATIVE AGENTS. J H Kofi Bonney, PhD
USING ADVANCED GENOMIC ANALYSIS FOR POTENTIAL HAEMORRHAGIC FEVER CAUSATIVE AGENTS J H Kofi Bonney, PhD Noguchi Memorial Institute Medical Research Noguchi Memorial Institute for Medical Research University
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI OUTLINE PRESENTATION Historical perspective Vision, Mission, Core values Functions of UVRI and achievements HISTORIC PERSPECTIVE Established in 1936
IN VIVO STUDIES ON VIRAL VIRULENCE
IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease
Cristina Cassetti, Ph.D.
NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID
Influenza & Other Respiratory Viruses Update
Influenza & Other Respiratory Viruses Update 2013-2014 Pete Shult, PhD. Director, Communicable Disease Division and Emergency Response Erik Reisdorf, MPH M (ASCP) CM Team Lead, Virology Laboratory WCLN
Overview of the Influenza Virus
Overview of the Influenza Virus Victor C. Huber, Ph.D. September 24, 2015 victor.huber@usd.edu General Features of Influenza Virus Infections Clinical Features of Influenza Sudden onset of symptoms Incubation
Appropriate Quality regarde as
A systematic review of antibiotic prescription associated with upper respiratory tract infections in China (Jing Li, MS 1 ) Supplemental Digital Content-Table 1. Quality assessment of included studies
Immunopathogenesis of Dengue Hemorrhagic Fever
Immunopathogenesis of Dengue Hemorrhagic Fever Carlos A. Sariol, MD, MS. Associated Investigator School of Medicine, MSC-UPR September 17th, 2009 Foro Educativo para Maestros de Ciencias en la UPRH September
The Biology of Viruses MMI / Biochem 575 SPRING 2015
The Biology of Viruses MMI / Biochem 575 SPRING 2015 INSTRUCTORS: Professor Paul Friesen Professor Andrew Mehle INTRODUCTION: The goal of Biology of Viruses (MMI/Biochem 575) is to introduce upperlevel
Virology Current viruses Clinical presentation Diagnosis Management antivirals and supportive Vaccination Emergency preparedness Surveillance and
Virology Current viruses Clinical presentation Diagnosis Management antivirals and supportive Vaccination Emergency preparedness Surveillance and predicting a pandemic Influenza- disaster from heaven Italian
Dengue Stephen J. Thomas, MD Director, Viral Diseases Branch Walter Reed Army Institute of Research (WRAIR) 14 AUG 2012
Dengue Stephen J. Thomas, MD Director, Viral Diseases Branch Walter Reed Army Institute of Research (WRAIR) 14 AUG 2012 Dengue Lecture Outline Dengue Virus Dengue Epidemiology Military Significance Clinical
MEEGID XII. Ebola viruses: from the wild to humans
MEEGID XII Bangkok, 11-13 December 2014 Ebola viruses: from the wild to humans Jean-Claude Piffaretti Interlifescience, Massagno, Switzerland 1. Animal viruses jumping to humans 2. Influenza virus A 3.
19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics
9 Viruses CAMPBELL BIOLOGY TENTH EDITION Reece Urry Cain Wasserman Minorsky Jackson Outline I. Viruses A. Structure of viruses B. Common Characteristics of Viruses C. Viral replication D. HIV Lecture Presentation
What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital
What s new in Infectious Diseases Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital None Disclosures Objectives New information in infectious diseases. New diseases and outbreaks.
MIPH2014 Conference Schedule
MIPH2014 Conference Schedule May 7, 2014 From To 08:00 AM 06:00 PM All approved participants will have meals for free at the dinning hall of Jiayuan hotel Check In 12:00 PM 01:00 PM Lunch 06:00 PM 07:00
What is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome
What is influenza virus? 13,000 base RNA genome: 1/246153 the size of the human genome CDC Principles of Virology, 4e Neumann et al. Nature. 2009. Influenza virus is one of the most deadly viral pathogens
Field research to iden/fy infec/ous agents in animals and the environment to a6empt to predict emergence
Field research to iden/fy infec/ous agents in animals and the environment to a6empt to predict emergence John S Mackenzie Plenary session 3: Policies and Strategies to Meet the Challenge of Emerging Disease
LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
DISCLOSURES. I have no actual or potential conflicts of interest in this presentation.
OVERVIEW ON MEASLES Oneka B. Marriott, DO, MPH, FAAP, FACOP Assistant Professor of Pediatrics and Public Health Nova Southeastern University College of Osteopathic Medicine Presentation to FSACOFP Annual
Early February Surveillance of severe atypical pneumonia in Hospital Authority in Hong Kong. Initiate contacts in Guangdong
SARS: Aetiology JSM Peiris The University of Hong Kong & Queen Mary Hospital WHO SARS Laboratory Network Hospital Authority and Department of Health, HK Early February 2003 Surveillance of severe atypical
Equine influenza at the human animal interface Ann Cullinane Irish Equine Centre
Equine influenza at the human animal interface Ann Cullinane Irish Equine Centre Interspecies transmission of H3N8 equine viruses Dogs racing greyhounds in Florida >95% sequence homology with recent equine
FAO component of the USAID EPT-2 programme
AGENDA FAO component of the USAID EPT-2 programme Working meeting on risk modeling and assessment Rome, Italy 28-30 June 2016 28 June Tuesday 09:00 09:10 Welcome and introduction of participants J. Lubroth
The making of Bovela - a vaccine against bovine viral diarrhea
The making of Bovela - a vaccine against bovine viral diarrhea Konrad Stadler, Boehringer Ingelheim Veterinary Research Center Manchester. January 6, 2016 Vaccines In general, a vaccine should be safe
PARALLEL SESSION 2.4
PARALLEL SESSION 2.4 CHANGING DYNAMICS: EMERGING INFECTIOUS DISEASES AND ANTIMICROBIAL RESISTANCE IN AN ERA OF EXPANDING GLOBAL HUMAN POPULATION GROWTH AND MOVEMENT BACKGROUND The global human population
Infection Basics. Lecture 12 Biology W3310/4310 Virology Spring 2016
Infection Basics Lecture 12 Biology W3310/4310 Virology Spring 2016 Before I came here I was confused about this subject. Having listened to your lecture, I am still confused but at a higher level. ENRICO